Sep 24, 2021
N-Nitrosodimethylamine levels in Ranitidine Medications are Unacceptably High, Leading to a Ban in Several Countries
N-Nitrosodimethylamine levels in Ranitidine Medications are Unacceptably High, Leading to a Ban in Several Countries
Ranitidine, marketed under the trade names Zantac and others, is a medicine used to reduce stomach acid production. It was originally authorized in the United States in 1983. The US Food and Drug Administration approved Glaxo Holdings Ltd., which was later purchased by GlaxoSmithKline PLC, to commercialize Zantac. It was authorized for the treatment of ulcers and heartburn. It was given to treat…
View On WordPress